Research Manitoba will match industry contributions to projects at a 1:1 ration, up to $25,000 per year for up to two years. NSERC will match industry contributions to projects at a 2:1 ratio, from $20,000 to $1M per year for up to five years.
Shown to provide strong efficacy with a good tolerability profile
The study looked at the effects of heparin, a generic blood thinner, in moderately and severely ill COVID-19 patients in nine countries.
This five-pillar national strategy signals the federal government’s commitment to collaborating with industry and other stakeholders in ensuring a robust life sciences sector to develop and deliver innovative medicines and vaccines.
SciMar Ltd. hopes to create a preventative neutraceutical
The $4.95 million, to be doled out over the next six years, will support programs at the U of M, the University of Guelph and McGill University, as well as seven additional institutions.
The Richardson Centre for Functional Foods and Nutraceuticals (RCFFN) at the University of Manitoba (UM) has been approved for a licence under the Safe Food for Canadians Regulations (SFCR)
The Canadian Prairie Metabolic Network (CPMN) will provide access to a full range of multidisciplinary expertise, develop best practice approaches, and provide, as needed, clinical specialist coverage for generalist physicians and their patients.
The treatment of chronic wounds is a major challenge for health care providers,DispersinB® hydrogel will significantly increase the ability of healthcare providers to effectively treat wound infections and complement other treatments.
The priority areas for the research include novel therapeutics, remote access and artificial intelligence, Indigenous health, improvements to quality of care, and/or improvements to geriatric care.
The theme of this issue: Teamwork Against The Coronas!
Intrinsic Analytics, Manitoba’s premier bioinformation services provider, offers occupation health services, personal health services, COVID-19 testing, and consultations for its different programs.
MindSet and Novartis Pharmaceuticals Canada Inc. are working together to learn more about uncontrolled cholesterol, the impact on Manitobans and their families, as well as the healthcare system as a whole.
WD funding will enable Prairie Fava to scale-up its operations to capture new opportunities within the fava bean market.
The Canada Revenue Agency’s Scientific Research and Experimental
Development (SR&ED) Program is a federal tax incentive program.
Since the pandemic began, more than half a dozen industry organizations have welcomed new leaders
Dynacare Labs is expected to expand sequencing capacity in Manitoba to check for the highly infectious and potentially more dangerous Delta B.1617 variant.
Get a financial contribution to develop a transformative clean technology or to expand a current technology. Use this support for pre-market innovation, including research, development, demonstration, and commercialization activities.
Cubresa is launching its clinical product, the BrainPET, a PET insert
designed for use in an MR scanner, enabling simultaneous PET/MRI
imaging of the brain.
During the pandemic, Winnipeg’s Precision ADM became one of the best examples of a resurgent Canadian supply chain for personal protective equipment and medical device products.
BAM's 2023 Most Promising Bioscience Student, Daniel Gussakovsky, and recent scholarship winner, shares about his research, why he's chosen it, and what he hopes to do in the future with it.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.